Developing culturally safe education practices in optometry schools across Australia and Aotearoa New Zealand.


Journal

Clinical & experimental optometry
ISSN: 1444-0938
Titre abrégé: Clin Exp Optom
Pays: United States
ID NLM: 8703442

Informations de publication

Date de publication:
03 2023
Historique:
pubmed: 8 11 2022
medline: 4 3 2023
entrez: 7 11 2022
Statut: ppublish

Résumé

Access to culturally safe health services is a basic human right, however through the lasting effects of colonisation, oppression, and systemic racism, the individual and community health of Indigenous peoples in Australia and Aotearoa New Zealand have been severely impacted. The Aboriginal and Torres Strait Islander Health and Cultural Safety Strategy of the Australian Health Practitioners Regulation Agency, and the Standards of Cultural Competence and Cultural Safety of the Optometrists and Dispensing Opticians Board of New Zealand, recognise the importance of access to safe health care for Aboriginal, Torres Strait Islander and Māori patients, which encompasses both clinical competency and cultural safety. Universities have an ongoing responsibility to ensure their learning and teaching activities result in graduates being able to provide culturally safe practice. This article highlights the emergence of culturally safe practices in the Australian and Aotearoa New Zealand optometry curricula over the last five years incorporating Indigenous ways of knowing, being and doing into the curricula, understanding the local Indigenous histories and contexts, the adoption of online cultural education modules, and clinical placement partnerships with local Indigenous communities. Whilst there is still much work to do to achieve the goal of graduating culturally safe optometrists, this paper focuses on features that enable or impede progress in the development of culturally safe practices within the optometry programmes to improve eye health equity for Indigenous recognise the diversity of Indigenous cultures across Australia and NZ.

Identifiants

pubmed: 36336833
doi: 10.1080/08164622.2022.2136514
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-118

Auteurs

Nicola S Anstice (NS)

Optometry and Vision Science, Flinders University, Adelaide, Australia.

Khyber Alam (K)

Division of Optometry, University of Western Australia, Perth, Australia.

James A Armitage (JA)

School of Medicine (Optometry), Deakin University, Geelong, Australia.

Brett Biles (B)

Office of Medical Education, University of New South Wales, Sydney, Australia.

Joanna M Black (JM)

School of Optometry and Vision Science, The University of Auckland, Aotearoa New Zealand.

Mei Ying Boon (MY)

Optometry and Vision Science, University of Canberra, Bruce, Australia.

Teah Carlson (T)

College of Health, Massey University, Aotearoa, New Zealand.

Holly R Chinnery (HR)

Department of Optometry and Vision Science, The University of Melbourne, Melbourne, Australia.

Andrew V Collins (AV)

School of Optometry and Vision Science, The University of Auckland, Aotearoa New Zealand.

Anthea Cochrane (A)

Department of Optometry and Vision Science, The University of Melbourne, Melbourne, Australia.

Debbie Duthie (D)

School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, Australia.

Shelley Hopkins (S)

School of Optometry and Vision Science, Faculty of Health, Queensland University of Technology, Australia.

Gary Fitzpatrick (G)

Division of Optometry, University of Western Australia, Perth, Australia.

Lisa Keay (L)

School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.

Renata Watene (R)

School of Optometry and Vision Science, The University of Auckland, Aotearoa New Zealand.

Aryati Yashadhana (A)

Office of Medical Education, University of New South Wales, Sydney, Australia.

Sharon A Bentley (SA)

School of Optometry and Vision Science, Faculty of Health, Queensland University of Technology, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH